A detailed history of ETF Managers Group, LLC transactions in Inovio Pharmaceuticals, Inc. stock. As of the latest transaction made, ETF Managers Group, LLC holds 86,366 shares of INO stock, worth $351,509. This represents 0.0% of its overall portfolio holdings.

Number of Shares
86,366
Previous 62,201 38.85%
Holding current value
$351,509
Previous $97,000 27.84%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 17, 2023

BUY
$0.79 - $1.91 $19,090 - $46,155
24,165 Added 38.85%
86,366 $70,000
Q4 2022

Mar 23, 2023

SELL
$1.41 - $2.5 $16,068 - $28,490
-11,396 Reduced 15.48%
62,201 $97,000
Q3 2022

Nov 14, 2022

BUY
$1.66 - $2.79 $2,050 - $3,445
1,235 Added 1.71%
73,597 $127,000
Q2 2022

Aug 15, 2022

BUY
$1.44 - $3.98 $12,304 - $34,009
8,545 Added 13.39%
72,362 $130,000
Q1 2022

May 13, 2022

BUY
$2.97 - $5.2 $692 - $1,211
233 Added 0.37%
63,817 $233,000
Q4 2021

Feb 14, 2022

SELL
$4.99 - $7.46 $65,992 - $98,658
-13,225 Reduced 17.22%
63,584 $330,000
Q3 2021

Nov 15, 2021

BUY
$7.16 - $9.69 $107,722 - $145,786
15,045 Added 24.36%
76,809 $558,000
Q2 2021

Aug 16, 2021

SELL
$6.23 - $10.03 $11,893 - $19,147
-1,909 Reduced 3.0%
61,764 $584,000
Q1 2021

May 17, 2021

SELL
$8.81 - $16.96 $164,976 - $317,592
-18,726 Reduced 22.73%
63,673 $561,000
Q4 2020

Feb 16, 2021

SELL
$8.5 - $12.85 $209,542 - $316,778
-24,652 Reduced 23.03%
82,399 $742,000
Q3 2020

Nov 16, 2020

BUY
$9.57 - $27.05 $430,946 - $1.22 Million
45,031 Added 72.61%
107,051 $1.21 Million
Q2 2020

Aug 14, 2020

BUY
$7.14 - $31.69 $442,822 - $1.97 Million
62,020 New
62,020 $1.97 Million

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $1.02B
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track ETF Managers Group, LLC Portfolio

Follow ETF Managers Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.